Wadworth A N, Goa K L
Adis International Limited, Auckland, New Zealand.
Drugs. 1991 Dec;42(6):1018-60. doi: 10.2165/00003495-199142060-00009.
The antibacterial efficacy of oral lomefloxacin has been investigated in a wide variety of infections, including respiratory and uncomplicated and complicated urinary tract infections, obstetric, gynaecological, joint, skin, oral, ear, nose, throat and eye infections. It has also been used as an otic solution in patients with otitis media and as an ophthalmic solution in the treatment of eye infections. In clinical trials its efficacy is equivalent to that of other quinolones and it is at least as effective as other antibacterial drugs ordinarily used in these infections. Lomefloxacin offers certain advantages compared with other quinolone antibacterial drugs in that it may be conveniently administered once daily and theophylline dosage adjustment does not appear to be necessary in patients receiving this bronchodilator concomitantly. Thus, orally administered lomefloxacin should prove a useful broad spectrum antibacterial drug for a wide variety of clinical infections.
口服洛美沙星的抗菌疗效已在多种感染中得到研究,包括呼吸道感染、单纯性和复杂性尿路感染、妇产科感染、关节感染、皮肤感染、口腔感染、耳感染、鼻感染、咽喉感染和眼部感染。它还被用作中耳炎患者的耳用溶液以及治疗眼部感染的眼用溶液。在临床试验中,其疗效与其他喹诺酮类药物相当,并且至少与通常用于这些感染的其他抗菌药物一样有效。与其他喹诺酮类抗菌药物相比,洛美沙星具有某些优势,因为它可以方便地每日给药一次,并且对于同时接受这种支气管扩张剂治疗的患者,似乎无需调整茶碱剂量。因此,口服洛美沙星应被证明是一种用于多种临床感染的有用的广谱抗菌药物。